• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氯喹耐药性对疟疾死亡率的影响。

Impact of chloroquine resistance on malaria mortality.

作者信息

Trape J F, Pison G, Preziosi M P, Enel C, Desgrées du Loû A, Delaunay V, Samb B, Lagarde E, Molez J F, Simondon F

机构信息

Laboratoire de paludologie, Orstom, Dakar, Senegal.

出版信息

C R Acad Sci III. 1998 Aug;321(8):689-97. doi: 10.1016/s0764-4469(98)80009-7.

DOI:10.1016/s0764-4469(98)80009-7
PMID:9769862
Abstract

Over 12 years, from 1984 to 1995, we conducted a prospective study of overall and malaria specific mortality among three rural populations in the Sahel, savanna and forest areas of Senegal. The emergence of chloroquine resistance has been associated with a dramatic increase in malaria mortality in each of the studied populations. After the emergence of chloroquine resistance, the risk of malaria death among children 0-9 years old in the three populations was multiplied by 2.1, 2.5 and 5.5, respectively. This is the first study to document malaria mortality at the community level in Africa before and after the emergence of chloroquine resistance. Findings suggest that the spread of chloroquine resistance has had a dramatic impact on the level of malaria mortality in most epidemiological contexts in tropical Africa.

摘要

从1984年到1995年的12年间,我们对塞内加尔萨赫勒、稀树草原和森林地区的三个农村人口的总体死亡率和疟疾特异性死亡率进行了前瞻性研究。氯喹耐药性的出现与每个研究人群中疟疾死亡率的急剧上升有关。氯喹耐药性出现后,这三个人口中0至9岁儿童的疟疾死亡风险分别增加到原来的2.1倍、2.5倍和5.5倍。这是第一项记录非洲氯喹耐药性出现前后社区层面疟疾死亡率的研究。研究结果表明,氯喹耐药性的传播对热带非洲大多数流行病学环境中的疟疾死亡率水平产生了巨大影响。

相似文献

1
Impact of chloroquine resistance on malaria mortality.氯喹耐药性对疟疾死亡率的影响。
C R Acad Sci III. 1998 Aug;321(8):689-97. doi: 10.1016/s0764-4469(98)80009-7.
2
The public health impact of chloroquine resistance in Africa.氯喹耐药性在非洲对公共卫生的影响。
Am J Trop Med Hyg. 2001 Jan-Feb;64(1-2 Suppl):12-7. doi: 10.4269/ajtmh.2001.64.12.
3
Evolution of malaria mortality and morbidity after the emergence of chloroquine resistance in Niakhar, Senegal.在塞内加尔尼奥阿克出现氯喹耐药性后,疟疾死亡率和发病率的演变。
Malar J. 2009 Nov 27;8:270. doi: 10.1186/1475-2875-8-270.
4
Combating malaria in Africa.在非洲抗击疟疾。
Trends Parasitol. 2002 May;18(5):224-30. doi: 10.1016/s1471-4922(02)02249-3.
5
The mortality consequences of the continued use of chloroquine in Africa: experience in Siaya, western Kenya.在非洲持续使用氯喹的死亡后果:肯尼亚西部锡亚的经验
Am J Trop Med Hyg. 2003 Apr;68(4):386-90.
6
[In vivo chemosensitivity tests of Plasmodium falciparum to chloroquine in Senegal: the development of resistance and the assessment of therapeutic efficacy].[塞内加尔恶性疟原虫对氯喹的体内化学敏感性试验:耐药性的发展及治疗效果评估]
Bull Soc Pathol Exot. 1997;90(2):83-9.
7
[Chloroquine resistant strains of Plasmodium falciparum in the Anopheles vector and use of antimalarials].[按蚊载体中恶性疟原虫的氯喹抗性菌株及抗疟药的使用]
Dakar Med. 1996;Spec No:7-9.
8
[Decision making policies on the utilization of antimalarials in response to a modification of chloroquine efficacity. Applications to Africa].[针对氯喹疗效改变的抗疟药使用决策政策。在非洲的应用]
Med Trop (Mars). 1995;55(4 Suppl):37-40.
9
[Impact of antimalarial drug accessibility on malarial morbidity and chloroquine resistance. A study carried out in Touba (Senegal)].[抗疟药物可及性对疟疾发病率和氯喹耐药性的影响。在图巴(塞内加尔)开展的一项研究]
Bull Soc Pathol Exot. 1997;90(5):318-20.
10
[In vivo evaluation of Plasmodium falciparum sensitivity to chloroquine in Moundou, Chad].
Med Trop (Mars). 1995;55(3):286.

引用本文的文献

1
Bionomics of Anopheles gambiae complex (Diptera: Culicidae) and malaria transmission pattern in a pre-elimination area in South-Western Senegal.塞内加尔西南部一个疟疾消除前地区冈比亚按蚊复合体(双翅目:蚊科)的生物学特性及疟疾传播模式
Malar J. 2025 Jul 4;24(1):215. doi: 10.1186/s12936-025-05411-9.
2
Single low dose primaquine to block the transmission of Plasmodium falciparum-proposed stand-alone and ACT-adapted regimens.单剂量低剂量伯氨喹阻断恶性疟原虫传播——拟用的单独用药方案和与青蒿素联合疗法适配的方案
BMC Med. 2025 Jul 1;23(1):397. doi: 10.1186/s12916-025-04153-4.
3
Supplementing routine hospital surveillance of malaria to capture excess mortality and epidemiological trends: a five-year observational study.
补充疟疾常规医院监测以捕捉额外死亡率和流行病学趋势:一项为期五年的观察性研究。
Front Malar. 2024;2. doi: 10.3389/fmala.2024.1340276. Epub 2024 Apr 16.
4
Identification of an artemisinin-resistant kelch13 R515K mutant parasite in Senegal.在塞内加尔发现一株对青蒿素耐药的kelch13基因R515K突变疟原虫。
Front Parasitol. 2023 Apr 28;2:1076759. doi: 10.3389/fpara.2023.1076759. eCollection 2023.
5
Anti-infectivity efficacy and pharmacokinetics of WHO recommended single low-dose primaquine in children with acute Plasmodium falciparum in Burkina Faso: study protocol.世卫组织推荐的单剂低剂量伯氨喹在布基纳法索急性恶性疟原虫感染儿童中的抗感染力疗效和药代动力学:研究方案。
Trials. 2024 Sep 3;25(1):583. doi: 10.1186/s13063-024-08428-8.
6
Two decades of molecular surveillance in Senegal reveal rapid changes in known drug resistance mutations over time.二十年来,塞内加尔的分子监测揭示了已知耐药突变体随时间的快速变化。
Malar J. 2024 Jul 9;23(1):205. doi: 10.1186/s12936-024-05024-8.
7
Access to quality-assured artemisinin-based combination therapy and associated factors among clients of selected private drug outlets in Uganda.乌干达部分私立药店客户获得有质量保证的青蒿素复方疗法及相关因素
Malar J. 2024 Apr 30;23(1):128. doi: 10.1186/s12936-024-04956-5.
8
Efficacy of artesunate-amodiaquine for treatment of uncomplicated Plasmodium falciparum malaria in mainland Tanzania.青蒿琥酯-阿莫地喹治疗坦桑尼亚大陆无并发症恶性疟的疗效。
Malar J. 2024 Mar 29;23(1):90. doi: 10.1186/s12936-024-04923-0.
9
One hundred malaria attacks since birth. A longitudinal study of African children and young adults exposed to high malaria transmission.自出生以来经历100次疟疾发作。对暴露于高疟疾传播环境下的非洲儿童和青年成年人的纵向研究。
EClinicalMedicine. 2023 Dec 14;67:102379. doi: 10.1016/j.eclinm.2023.102379. eCollection 2024 Jan.
10
Modeling of malaria vaccine effectiveness on disease burden and drug resistance in 42 African countries.42个非洲国家疟疾疫苗效力对疾病负担及耐药性的建模分析
Commun Med (Lond). 2023 Oct 13;3(1):144. doi: 10.1038/s43856-023-00373-y.